# Impact of SGLT2 Inhibitors in Heart Transplant Recipients

> **NCT06147271** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Universidade Federal do Ceara** · enrollment: 80 (estimated)

## Conditions studied

- Transplant; Failure, Heart
- Cardiac Allograft Vasculopathy
- Rejection Heart Transplant

## Interventions

- **DRUG:** SGLT2i

## Key facts

- **NCT ID:** NCT06147271
- **Lead sponsor:** Universidade Federal do Ceara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-11-20
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06147271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06147271, "Impact of SGLT2 Inhibitors in Heart Transplant Recipients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06147271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*